Candesartan Cilexetil CAS 145040-37-5 Ubunyulu > 99.0% (HPLC) API Factory
Ubonelelo lweMichiza yeRuifu Candesartan Cilexetil ePhakathi ngokucoceka okuphezulu
Candesartan Cilexetil CAS 145040-37-5
Candesartan CAS 139481-59-7
I-1-Chloroethyl Cyclohexyl Carbonate CAS 99464-83-2
Candesartan Cilexetil Phakathi Eethyl Ester C6 CAS 139481-41-7
Candesartan Cilexetil Intermediate CAS 139481-44-0
I-Trityl Candesartan Cilexetil CAS 170791-09-0
Igama leMchiza | Candesartan Cilexetil |
Izithethantonye | I-TCV-116;1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H -benzo[d] imidazole-7-Carboxylate |
Inombolo yeCAS | 145040-37-5 |
Inombolo yeCAT | RF-PI1891 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C33H34N6O6 |
Ubunzima beMolekyuli | 610.66 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya kuMhlophe oMhlophe wePowder |
Ukuchongwa kwe-HPLC | Ixesha lokugcinwa kwencopho enkulu kwikhromatogram yesampulu ihambelana naleyo ikwichromatogram efunyenwe ngomgangatho |
Ukuchongwa kwe-IR | I-IR infrared absorption spectrum iyafana naleyo yeCandesartan Cilexetil yereferensi yomgangatho |
Ukucaca kunye nesisombululo soMbala | Isisombululo kwi-chloroform kwi-5% icacile kwaye ayinambala |
Ubunyulu / Indlela yokuHlalutya | >99.0% (HPLC) |
Indawo yokunyibilika | 155.0 ~ 160.0℃ |
Ilahleko ekomisweni | <0.30% |
Intsalela kwi-Ignition | <0.10% |
Iintsimbi ezinzima | <10ppm |
IArsenic (As) | <1ppm |
Ukuhanjiswa kobungakanani beNcam | 90% <30 μm |
Ukungcola Okuphilayo | nguHPLC |
Ethyl Candesartan | <0.15% |
Desethyl Candesartan | <0.15% |
N2-Ethyl Candesartan Cilexei | <0.15% |
Nakuphi na Ukungcola Okungaziwa | <0.15% |
Ukungcola ngokupheleleyo | <0.60% |
Uvavanyo lwePotentiometry | I-99.0 ~ 101.0% ye-C33H34N6O6, ibalwa kwizinto ezingenamanzi |
Ukungacoceki okuguquguqukayo kwe-Organic | |
Methano | <0.30% |
I-Ethanol | <0.50% |
I-Diethyl Ether | <0.50% |
IAceton | <0.50% |
IDichloromethan | <0.06% |
I-Dimethylformamide | <0.088% |
Ungcoliseko lweMicrobiological | |
Ubalo olupheleleyo lweAerobic Microbial | <1000cfu/g |
Umngundo kunye negwele | <100cfu/g |
E.Coli | Ukungabikho |
Salmonella | Ukungabikho |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | API;Iarhente yeAntihypertensive |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
I-Candesartan Cilexetil (TCV-116) (i-CAS: 145040-37-5) i-angiotensin II receptor antagonist kunye ne-IC50 ye-0.26 nM, esetyenziselwa unyango lwe-hypertension.I-Candesartan yi-angiotensin-receptor blocker (ARB) enokuthi isetyenziswe yodwa okanye kunye nezinye ii-agent ukunyanga uxinzelelo lwegazi.Ilawulwa ngomlomo njenge-prodrug, i-candesartan cilexetil, eguqulelwa ngokukhawuleza kwi-metabolite esebenzayo, i-candesartan, ngexesha lokufunxa kwi-gastrointestinal tract.I-Candesartan yehlisa uxinzelelo lwegazi ngokuchasa inkqubo ye-renin-angiotensin-aldosterone (RAAS);ikhuphisana ne-angiotensin II ngokubophelela kuhlobo lwe-1 i-angiotensin II receptor (AT1) i-subtype kwaye inqande uxinzelelo lwegazi olukhulayo iziphumo ze-angiotensin II.Ngokungafaniyo ne-angiotensin-converting enzyme (ACE) inhibitors, ii-ARB azinayo impembelelo embi yokukhwehlela okomileyo.I-Candesartan ingasetyenziselwa ukunyanga uxinzelelo lwegazi oluphezulu, uxinzelelo lwegazi lwe-systolic olulodwa, i-hypertrophy ye-ventricular yasekhohlo kunye ne-nephropathy yesifo seswekile.Inokusetyenziswa njengenye indlela yonyango lokungaphumeleli kwentliziyo, ukungasebenzi kakuhle kwe-systolic, i-myocardial infarction kunye nesifo se-coronary artery.